BACKGROUND/AIMS: There are few studies that evaluate the clinical outcomes of individuals with non-amnestic mild cognitive impairment (MCI). The purpose of this study was to evaluate baseline predictors of clinical progression after 2 years for patients with dysexecutive MCI (dMCI), a single-domain non-amnestic MCI subgroup. METHODS: We evaluated clinical progression in a sample of 31 older adults with dMCI. Clinical progression was defined as a worsening on the Clinical Dementia Rating sum of boxes at the 2-year visit, whereas patients were classified as stable if the score did not worsen over 2 years. We compared baseline brain MRI, neuropsychological tests, and health risk factors. RESULTS: Twelve individuals with dMCI progressed clinically, and 19 individuals remained stable over 2 years. Compared to the stable dMCI patients, the dMCI patients who progressed showed brain atrophy in the bilateral insula and left lateral temporal lobe on MRI. dMCI patients who progressed were also older, had lower baseline performance on category fluency and a spatial location task, and reported fewer dysexecutive symptoms. Health risk factors, except hypertension, did not differ between groups. CONCLUSION: The results suggest that dMCI patients who progress relatively quickly over 2 years may have unique clinical and brain MRI features.
BACKGROUND/AIMS: There are few studies that evaluate the clinical outcomes of individuals with non-amnestic mild cognitive impairment (MCI). The purpose of this study was to evaluate baseline predictors of clinical progression after 2 years for patients with dysexecutive MCI (dMCI), a single-domain non-amnestic MCI subgroup. METHODS: We evaluated clinical progression in a sample of 31 older adults with dMCI. Clinical progression was defined as a worsening on the Clinical Dementia Rating sum of boxes at the 2-year visit, whereas patients were classified as stable if the score did not worsen over 2 years. We compared baseline brain MRI, neuropsychological tests, and health risk factors. RESULTS: Twelve individuals with dMCI progressed clinically, and 19 individuals remained stable over 2 years. Compared to the stable dMCIpatients, the dMCIpatients who progressed showed brain atrophy in the bilateral insula and left lateral temporal lobe on MRI. dMCIpatients who progressed were also older, had lower baseline performance on category fluency and a spatial location task, and reported fewer dysexecutive symptoms. Health risk factors, except hypertension, did not differ between groups. CONCLUSION: The results suggest that dMCIpatients who progress relatively quickly over 2 years may have unique clinical and brain MRI features.
Authors: E J Burton; G Karas; S M Paling; R Barber; E D Williams; C G Ballard; I G McKeith; P Scheltens; F Barkhof; J T O'Brien Journal: Neuroimage Date: 2002-10 Impact factor: 6.556
Authors: Joel H Kramer; Jennifer Jurik; Sharon J Sha; Kate P Rankin; Howard J Rosen; Julene K Johnson; Bruce L Miller Journal: Cogn Behav Neurol Date: 2003-12 Impact factor: 1.600
Authors: Jennifer Molano; Bradley Boeve; Tanis Ferman; Glenn Smith; Joseph Parisi; Dennis Dickson; David Knopman; Neill Graff-Radford; Yonas Geda; John Lucas; Kejal Kantarci; Maria Shiung; Clifford Jack; Michael Silber; V Shane Pankratz; Ronald Petersen Journal: Brain Date: 2009-11-04 Impact factor: 13.501
Authors: M A Lambon Ralph; J Powell; D Howard; A B Whitworth; P Garrard; J R Hodges Journal: J Neurol Neurosurg Psychiatry Date: 2001-02 Impact factor: 10.154
Authors: Elliott J Mufson; Lester Binder; Scott E Counts; Steven T DeKosky; Leyla de Toledo-Morrell; Stephen D Ginsberg; Milos D Ikonomovic; Sylvia E Perez; Stephen W Scheff Journal: Acta Neuropathol Date: 2011-11-19 Impact factor: 17.088
Authors: E J Mufson; L Mahady; D Waters; S E Counts; S E Perez; S T DeKosky; S D Ginsberg; M D Ikonomovic; S W Scheff; L I Binder Journal: Neuroscience Date: 2015-03-12 Impact factor: 3.590
Authors: Stephen W Scheff; Douglas A Price; Mubeen A Ansari; Kelly N Roberts; Frederick A Schmitt; Milos D Ikonomovic; Elliott J Mufson Journal: J Alzheimers Dis Date: 2015 Impact factor: 4.472
Authors: Sheina Emrani; David J Libon; Melissa Lamar; Catherine C Price; Angela L Jefferson; Katherine A Gifford; Timothy J Hohman; Daniel A Nation; Lisa Delano-Wood; Amy Jak; Katherine J Bangen; Mark W Bondi; Adam M Brickman; Jennifer Manly; Rodney Swenson; Rhoda Au Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472
Authors: Edward D Huey; Jennifer J Manly; Ming-X Tang; Nicole Schupf; Adam M Brickman; Masood Manoochehri; Jesse Mez; Charles DeCarli; Davangere P Devanand; Richard Mayeux Journal: Alzheimers Dement Date: 2013-02-27 Impact factor: 21.566
Authors: Sarah Tomaszewski Farias; Elizabeth Chou; Danielle J Harvey; Dan Mungas; Bruce Reed; Charles DeCarli; Lovingly Quitania Park; Laurel Beckett Journal: Psychol Aging Date: 2013-12